Cannara Biotech, Inc. (LOVE) Stock Analysis | Price, Returns, Financials & Key Metrics

Mojo Score Change: Cannara Biotech, Inc. has changed its score on 24 Nov 2025. Click here to unlock latest mojo score!

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Positive results in May 25

OPERATING CASH FLOW(Y) Highest at CAD 16.8 MM
ROCE(HY) Highest at 17.21%
NET SALES(Q) Highest at CAD 27.33 MM

With ROE of -10.12%, it has a very attractive valuation with a 1.58 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Other Agricultural Products

Market cap

CAD 156 Million (Small Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.33

Return on Equity

-10.12%

Price to Book

1.58

Revenue and Profits:

Net Sales:

27 Million

(Quarterly Results - May 2025)

Net Profit:

4 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-6.18%

6 Months

36.89%

1 Year

116.88%

2 Years

101.2%

3 Years

42.13%

4 Years

39.17%

5 Years

0.0%

Cannara Biotech, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Cannara Biotech Reports Strong Growth Amidst Market Positioning Adjustments

Cannara Biotech, Inc. has recently experienced a change in its evaluation, reflecting shifts in financial metrics and market positioning. The company reported a valuation grade of very attractive, with strong cash flow and significant net profit growth, despite a negative return on equity. Its stock performance has notably outpaced broader market indices.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

109.97%

EBIT Growth (5y)

3.96%

EBIT to Interest (avg)

-2.93

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.46

Sales to Capital Employed (avg)

0.56

Tax Ratio

1.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.58

EV to EBIT

-19.68

EV to EBITDA

-56.04

EV to Capital Employed

1.44

EV to Sales

1.84

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.30%

ROE (Latest)

-10.12%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'25",
        "Nov'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "27.30",
          "val2": "25.10",
          "chgp": "8.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.70",
          "val2": "-0.50",
          "chgp": "240.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.20",
          "chgp": "-8.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.30",
          "val2": "6.30",
          "chgp": "15.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4.10",
          "val2": "2.30",
          "chgp": "78.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-21.00%",
          "val2": "-83.10%",
          "chgp": "6.21%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Aug'24",
        "Aug'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.70",
          "val2": "57.30",
          "chgp": "42.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.60",
          "val2": "-4.40",
          "chgp": "-163.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.70",
          "val2": "5.30",
          "chgp": "7.55%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "25.60",
          "val2": "21.20",
          "chgp": "20.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "6.40",
          "val2": "6.90",
          "chgp": "-7.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-219.10%",
          "val2": "-163.90%",
          "chgp": "-5.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - May'25 - QoQ

May'25

Nov'24

Change(%)

Net Sales

27.30

25.10

8.76%

Operating Profit (PBDIT) excl Other Income

0.70

-0.50

240.00%

Interest

1.10

1.20

-8.33%

Exceptional Items

7.30

6.30

15.87%

Consolidate Net Profit

4.10

2.30

78.26%

Operating Profit Margin (Excl OI)

-21.00%

-83.10%

6.21%

USD in Million.

Compare with Peers

Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

All Quarterly Results

Annual Results Snapshot (Consolidated) - Aug'24

Aug'24

Aug'23

Change(%)

Net Sales

81.70

57.30

42.58%

Operating Profit (PBDIT) excl Other Income

-11.60

-4.40

-163.64%

Interest

5.70

5.30

7.55%

Exceptional Items

25.60

21.20

20.75%

Consolidate Net Profit

6.40

6.90

-7.25%

Operating Profit Margin (Excl OI)

-219.10%

-163.90%

-5.52%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Aug 2024 is 42.58% vs 60.06% in Aug 2023

Consolidated Net Profit

YoY Growth in year ended Aug 2024 is -7.25% vs 200.00% in Aug 2023

All Annual Results

Company CV

About Cannara Biotech, Inc.

Cannara Biotech, Inc.

Other Agricultural Products

Cannara Biotech Inc. is a Canada-based vertically integrated cannabis company. The Company’s segments include indoor cannabis operations and electronic commerce retail. The indoor cannabis segment's operations include cultivation, processing and sale of dried cannabis and cannabis derivatives for the Quebec and Canadian market. The Company also operates as an electronic commerce retailer of United States hemp-based cannabidiol (CBD) products for the United States market. Its subsidiaries include Cannara Biotech (Quebec) Inc. and ShopCBD.com Inc.

Company Coordinates

Company Details

Suite 2050 - 1055 West Georgia Street, Royal Centre, P.O. Box 11121, VANCOUVER BC : V6E 3P3

Tel: 1 514 9139136

Registrar Details

Cannara Biotech, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Positive results in May 25

With ROE of -10.12%, it has a very attractive valuation with a 1.58 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Cannara Biotech Reports Strong Growth Amidst Market Positioning Adjustments

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - May'25 - QoQ

Annual Results Snapshot (Consolidated) - Aug'24

About Cannara Biotech, Inc.

Company Coordinates